Home»Member Spotlight»Physician Spotlight – Dr. Joseph Rosenthal

Physician Spotlight – Dr. Joseph Rosenthal

0
Shares
Pinterest Google+

ADVANCES: 2017 BRINGS NEW THERAPIES, NEW HOPE TO THOSE BATTLING PEDIATRIC CANCER

December 23, 2016 | by Dory Benford for City of Hope

Rosenthal-Joseph
Joseph Rosenthal, M.D., M.H.C.M.

From the City of Hope website– At the end of every year, we sit down with our physicians and scientists for their take on how cancer care will evolve in the year ahead. Our conversations are collected in a series we call, Advances.

*     *     *
“Great strides have been made in pediatric cancer and childhood disease treatment over the past few decades, and recent advances in the areas of gene therapy, immunotherapy and targeted therapy will continue to move the field forward in 2017. We spoke to Joseph Rosenthal, M.D., M.H.C.M., the Barron Hilton Chair in Pediatrics at City of Hope, about the most significant developments he anticipates in pediatric research and treatment.”

*     *     *
Read the full interview with Dr. Rosenthal and learn more about treatment advances, improvements to patient outcomes, research progress and targeted therapies, click here.

At LACMA, we’re always pleased to hear about the good work our member physicians are doing. Thank you Dr. Rosenthal for your contributions in the field of pediatric oncology and for the care you give your patients and their families.

Previous post

The Impact of MACRA on Group Practice

Next post

Female Doctors Have Healthier Patients, Study Suggests